Resolvin D3
| 中文名称 | Resolvin D3 |
|---|---|
| 中文同义词 | |
| 英文名称 | Resolvin D3 |
| 英文同义词 | Resolvin D3;5,7,9,13,15,19-Docosahexaenoic acid, 4,11,17-trihydroxy-, (4S,5Z,7E,9E,11R,13Z,15E,17S,19Z)- |
| CAS号 | 916888-47-6 |
| 分子式 | C22H32O5 |
| 分子量 | 376.49 |
| EINECS号 | |
| 相关类别 | 试剂盒-细胞分析试剂盒 |
| Mol文件 | 916888-47-6.mol |
| 结构式 |  |
Resolvin D3 性质
| 储存条件 | Store at -20°C |
|---|---|
| 溶解度 | DMF：50 mg/ml；乙醇：50 mg/ml； PBS（pH 7.4）：0.05 mg/ml |
| 形态 | 液体 |
| 颜色 | 无色至浅黄 |
Resolvin D3 (RvD3) 是二十二碳六烯酸 (DHA) 衍生的介体。Resolvin D3 在关节炎中失调，可减轻关节炎症。
RvD3 (RvD3; 10 nM) significantly inhibits tumor necrosis factor-α–induced NF-κB activation in A549 epithelial cells.
Resolvin D3 (RvD3; 100 ng/100 µl; IP; daily for 6 days) alleviates arthritis progression, reduces edema and limits leukocyte numbers in murine K/BxN-serum induced arthritis.
| Animal Model: | Male C57Bl/6 mice (12 weeks old) or ALX/fpr2/3 KO mice |
| Dosage: | 100 ng/100 µl |
| Administration: | IP; daily for 6 days |
| Result: | Alleviated arthritis progression, reduced edema and limited leukocyte numbers in murine K/BxN-serum induced arthritis. |
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-136540 | Resolvin D3 Resolvin D3 | 916888-47-6 | 25μg(265.6μM * 250μL in Ethanol) | 8800元 |